Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 21, 2025

Primary Completion Date

January 11, 2026

Study Completion Date

July 1, 2026

Conditions
Diabetes Mellitus, Type 2Nicotine Dependence, Cigarettes
Interventions
DRUG

Application of GLP-1RAs drugs

The pharmacological intervention will be given as an add-on to the standardised psychosocial T2DM treatment paradigm. Patients self-inject Semaglutide once a week or use other GLP-1RAs

DRUG

DPP-4i group

The pharmacological intervention will be given as an add-on to the standardised psychosocial T2DM treatment paradigm. Patients took the DPP-4i according to their actual needs.

Trial Locations (1)

200120

Department of Endocrinology, East Hospital, Tongji University School of Medicine, 150 Jimo Road, Shanghai, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER